EKF Diagnostics Holdings PLC
LSE:EKF

Watchlist Manager
EKF Diagnostics Holdings PLC Logo
EKF Diagnostics Holdings PLC
LSE:EKF
Watchlist
Price: 25.1 GBX -3.28% Market Closed
Market Cap: £109.3m

EKF Diagnostics Holdings PLC
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

EKF Diagnostics Holdings PLC
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
EKF Diagnostics Holdings PLC
LSE:EKF
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Research & Development
-$296m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Research & Development
-$185.8m
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
-16%
Creo Medical Group PLC
LSE:CREO
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inspiration Healthcare Group PLC
LSE:IHC
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
EMV Capital PLC
LSE:EMVC
Research & Development
-£1.1m
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
13%
No Stocks Found

EKF Diagnostics Holdings PLC
Glance View

Market Cap
109.3m GBX
Industry
Health Care

EKF Diagnostics Holdings Plc is a vitro diagnostics company, which designs and manufactures diagnostic equipment for use within point-of-care settings. The company is headquartered in Penarth, South Glamorgan. The company went IPO on 2002-06-05. The firm's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. Its Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen, Quo-Lab A1c, UltraCrit, DiaSpect, HemataStat II and Creamatocrit Plus. The company operates in Germany, the United States, Russia and the United Kingdom.

EKF Intrinsic Value
HIDDEN
Show

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett